A Study of Fludarabine Dosing in Children and Young Adults With B-cell Acute Lymphoblastic Leukemia
Clinical trial NCT07223021 · RECRUITING
Trial details
- NCT number
- NCT07223021
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-10-20
- Primary completion
- 2028-10-01
- Enrollment
- 65
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.